Skip to main content
. 2014 Sep 18;3(3):1043–1049. doi: 10.3390/jcm3031043

Figure 2.

Figure 2

Evolution of diuresis, urine osmolality and urine sodium in three patients with urea, furosemide or V2 antagonist (satavaptan) (data adapted form References [22,25,37]).